Skip to main content
. Author manuscript; available in PMC: 2016 Nov 18.
Published in final edited form as: Toxicol Pathol. 2012 Dec 21;41(2):343–360. doi: 10.1177/0192623312468517

Table 4.

Potential TAFLD/TASH mechanisms.

Hepatocellular necrosis Altered hepatic lipid metabolism
Lipotoxicity Proinflammatory cytokines
Insulin resistance with altered
  adipokines
Oxidative stress with decreased
  antioxidant levels
Mitochondrial dysfunction Metabolic endotoxemia
Endoplasmic reticulum stress Proteasomal dysfunction
Altered transmethylation/
  transulfuration
Decreased intestinal barrier function
Autophagy Altered intestinal microflora
Nuclear receptor activation Nutrient-toxicant interactions
Kupffer cell activation Liver sinusoidal endothelial cell damage
Carbonyl stress Priming and Sensitization
Epigenetic modifications Hypoxia

Note: TAFLD = toxicant-associated fatty liver disease; TASH = toxicant-associated steatohepatitis.